Is a complete ELDN research report available?

No complete published report is available for Eledon Pharmaceuticals, Inc. (ELDN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Eledon Pharmaceuticals, Inc. (ELDN)

NASDAQ: ELDN · USD

$3.41

+0.10 (+3.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ELDN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	263.6M
Net income (ttm)	-78.1M
EPS (ttm)	-$0.86
Shares out	77.3M
Volume	1,082,570
Beta	0.96
Price target	$9.00	+163.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -78.1M
EPS (ttm): -$0.86
Market cap: 263.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ELDN indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001404281
Company name	Eledon Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	28617K101
Employees	33
Employees Change	2%
Employees Change Percent	6.45
Enterprise value	$153.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US28617K1016
Last refreshed	2026-07-31
Market cap	$263.6M
Market cap category	Micro-Cap
Price	$3.41
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	ELDN
Website	https://eledon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.65%
FCF yield	-26.14%
P/B ratio	2.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-78.1M
Net Income Growth Years	0%
Profit Per Employee	$-2.4M
ROA	-35.1
Roa5y	-24.82
ROCE	-48.78
ROE	-72.68
Roe5y	-87.78
ROIC	-49.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.55%
Cagr3y	38.26%
Cagr5y	-11.86%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$146.7M
Cash	$111.1M
Current Assets	$113.6M
Current Liabilities	$13.5M
Debt	$555,000
Debt Equity	$0.01
Equity	$100.5M
Liabilities	$46.2M
Long Term Assets	$33.1M
Long Term Liabilities	$32.8M
Net Cash	$110.5M
Net Cash By Market Cap	$41.93
Net Cash Growth	-10.86%
Net Debt Equity	$-1.1
Tangible Book Value	$68.1M
Tangible Book Value Per Share	$0.9
WACC	9.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.44
Net Working Capital	$-10.6M
Quick ratio	8.3
Working Capital	$100.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-50.11%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.54%
200-day SMA	2.9
3Y total return	164.34%
50-day SMA	3.76
50-day SMA vs 200-day SMA	50over200
5Y total return	-46.8%
All Time High	155
All Time High Change	-97.8%
All Time High Date	2018-06-01
All Time Low	1.07
All Time Low Change	218.69%
All Time Low Date	2023-11-09
ATR	0.24
Beta	0.96
Beta1y	2.75
Beta2y	1.48
Ch YTD	125.8
High	3.43
High52	4.6
High52 Date	2025-11-03
High52ch	-25.87%
Low	3.3
Low52	1.35
Low52 Date	2025-11-21
Low52ch	152.59%
Ma50ch	-9.31%
Premarket Change Percent	1.81
Premarket Price	$3.37
Premarket Volume	833
Price vs 200-day SMA	17.75%
RSI	39.63
RSI Monthly	50.9
RSI Weekly	52.15
Sharpe ratio	0.6x
Sortino ratio	0.84
Total Return	-50.11%
Tr YTD	125.8
Tr1m	-12.11%
Tr1w	-8.82%
Tr3m	2.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$8
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.16
Operating Income	$-86.5M
Price target	$9
Price Target Change	$164
Price Target Change Top	$135

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	70,848,139%
Float Percent	91.65%
Shares Insiders	0.06%
Shares Institutions	51.75%
Shares Out	77,302,331
Shares Qo Q	17.2%
Shares Yo Y	50.11%
Short Float	7.8%
Short Ratio	2.89
Short Shares	7.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-78.7M
Adjusted OCF	-78,682,000
Average Volume	1,186,334.95x
Bv Per Share	1.32
Ch1m	-12.11
Ch1w	-8.82
Ch1y	12.54
Ch3m	2.1
Ch3y	164.3
Ch5y	-46.8
Ch6m	58.61
Change	3.02%
Change From Open	1.79
Close	3.31
Days Gap	1.21
Dollar Volume	3,691,563.7
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-65M
EBITDA	$-65M
EPS	$-0.86
F Score	1
FCF	$-68.9M
FCF EV Yield	-45.01x
FCF Per Share	$-0.89
Financing CF	53,692,000
Fiscal Year End	December
Founded	2,004
Income Tax	$35,000
Investing CF	12,857,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2020-10-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	3.06
Ma150ch	11.51%
Ma20	3.82
Ma20ch	-10.76%
Net CF	-2,344,000
Next Earnings Date	2026-08-13
Open	3.35
Optionable	Yes
Position In Range	88.46
Post Close	3.41
Postmarket Change Percent	2.63
Postmarket Price	$3.5
Ppne	530,000
Pre Close	3.31
Price Date	2026-07-30
Ptbv Ratio	3.87
Relative Volume	0.91x
Share Based Comp	9,789,000
Tr6m	58.61%
Us State	California
Volume	1,082,570

Eledon Pharmaceuticals, Inc. (ELDN)

Coverage state: Market snapshot only — no published research

Generate the first ELDN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ELDN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ELDN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ELDN

Frequently asked questions